Last Updated : October 27, 2010
Details
FilesGeneric Name:
Febuxostat
Project Status:
Complete
Therapeutic Area:
Gout
Manufacturer:
Takeda Canada Inc.
Call for patient/clinician input open:
Brand Name:
Uloric
Project Line:
Reimbursement Review
Project Number:
SR0213-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Gout
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : October 27, 2010